This position paper has been approved by the AASLD and represents the position of the association. ## Preamble These recommendations provide a data-supported approach. They are based on the following: (1) formal review and analysis of the recently published world literature on the topic; (2) Amer
Liver biopsy
β Scribed by Don C. Rockey; Stephen H. Caldwell; Zachary D. Goodman; Rendon C. Nelson; Alastair D. Smith
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 417 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
I can hardly share the passionate enthusiasm of Breuhahn et al. for the ''dramatic'' improvements in understanding of molecular pathogenesis of hepatocellular carcinoma (HCC) and the claim for ''further rationally designed clinical trials based on molecular evidence''. 1 Among the causes of HCC, the
There is controversy about the frequency of and risk factors rate of 0.2% to 1.8%. 1,2,3,4,5 Most complications are caused for infectious complications of percutaneous liver biopsy in by either lung perforation or bleeding from lacerated interliver transplant recipients. The aim of this study was to